Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis

Authors Information
Article Notes and Dates
To Cite : Graham S, Harrod M, Iversen J, Simone Hocking J. Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis, Hepat Mon. 2016 ;16(7):e38640. doi: 10.5812/hepatmon.38640.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Hepatitis c virus projections working group: Estimates and projections of the hepatitis c virus epidemic in Australia. 2006;
  • 2. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev. 1996; 18(2): 137-48[PubMed]
  • 3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 4. The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples. 2015;
  • 5. The health of Australia's prisoners. 2012;
  • 6. Fourth National Aboriginal and Torres Strait Islander Blood-borne Viruses and Sexually Transmissible Infections Strategy, 2014-2017. 2014;
  • 7. Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008; 9(6): 585-95
  • 8. Main findings, bloodborne viral and sexually transmitted infections in aboriginal and torres strait islander people: Surveillance and evaluation report. 2015;
  • 9. Iversen J, Maher L. Australian needle and syringe program survey. 2015;
  • 10. Iversen J, Wand H, Topp L, Kaldor J, Maher L. Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health. 2013; 103(8): 1436-44[DOI][PubMed]
  • 11. Nguyen O. Needle syringe programs: A return on investment. 2010; 17
  • 12. Kwon JA, Anderson J, Kerr CC, Thein HH, Zhang L, Iversen J, et al. Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS. 2012; 26(17): 2201-10[DOI][PubMed]
  • 13. Dore GJ. The changing therapeutic landscape for hepatitis C. Med J Aust. 2012; 196(10): 629-32[PubMed]
  • 14. Doctors prescribing new hepatitis C treatments from today. 2016;
  • 15. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339[DOI][PubMed]
  • 16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 557-60[DOI][PubMed]
  • 17. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007; 36(3): 666-76[DOI][PubMed]
  • 18. Boston RC, Sumner AE. STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol. 2003; 537: 353-69[PubMed]
  • 19. Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997; 166(3): 127-30[PubMed]
  • 20. Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996. Aust N Z J Public Health. 1999; 23(4): 377-84[PubMed]
  • 21. Roberts C, Crofts N. Hitting up in the top end: characteristics of needle exchange clients in Darwin. Aust N Z J Public Health. 2000; 24(1): 82-5[PubMed]
  • 22. Gilles M, Swingler E, Craven C, Larson A. Prison health and public health responses at a regional prison in Western Australia. Aust N Z J Public Health. 2008; 32(6): 549-53[DOI][PubMed]
  • 23. van der Poorten D, Kenny DT, George J. Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Med J Aust. 2008; 188(10): 610-4[PubMed]
  • 24. Templeton DJ, Tyson BA, Meharg JP, Habgood KE, Bullen PM, Malek S, et al. Aboriginal health worker screening for sexually transmissible infections and blood-borne viruses in a rural Australian juvenile correctional facility. Sex Health. 2010; 7(1): 44-8[DOI][PubMed]
  • 25. Ward J, Topp L, Iversen J, Wand H, Akre S, Kaldor J, et al. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs. Aust N Z J Public Health. 2011; 35(5): 421-6[DOI][PubMed]
  • 26. Davies J, Jabbar Z, Gagan F, Baird RW. Blood-borne viruses in the haemodialysis-dependent population attending Top End Northern Territory facilities 2000-2009. Nephrology (Carlton). 2012; 17(5): 501-7[DOI][PubMed]
  • 27. Paquette D, McEwan M, Bryant J. Risk practices among aboriginal people who inject drugs in New South Wales, Australia. AIDS Behav. 2013; 17(7): 2467-73[DOI][PubMed]
  • 28. Foy A, Tierney A. Internal medicine in the bush: a clinical audit of a rural and remote outreach programme. Intern Med J. 2014; 44(4): 369-74[PubMed]
  • 29. Luciani F, Bretana NA, Teutsch S, Amin J, Topp L, Dore GJ, et al. A prospective study of hepatitis C incidence in Australian prisoners. Addiction. 2014; 109(10): 1695-706[DOI][PubMed]
  • 30. Parker C, Tong SY, Dempsey K, Condon J, Sharma SK, Chen JW, et al. Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome. Med J Aust. 2014; 201(8): 470-4[PubMed]
  • 31. Harrod ME, Dore GJ, Gregson S, Belfrage M, Delaney-Thiele D, Hammond B. A descriptive analysis of routine HCV testing data from four Aboriginal Community Controlled Health Services: testing, positivity, follow-up and context of testing. 2014;
  • 32. Saulo D, Harrod ME, Reekie J, Kaldor J, Butler T. Blood borne virus prevalence and risk behaviours in Indigenous and non-Indigenous prison entrants. 2014;
  • 33. Su JY, Broadfoot J. Sero-prevalence of hepatitis C virus antibody among prisoners in the Northern territory. 2013; 20
  • 34. Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 2012; 126(1-2): 156-60[DOI][PubMed]
  • 35. Sexual health and bloodborne viruses. 2012;
  • 36. Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, et al. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust. 2014; 200(5): 277-80[PubMed]
  • 37. Butler T, Callander D, Simpson M. National prison entrants’ bloodborne virus and risk behaviour survey 2004, 2007, 2010 and 2013. 2015;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check